$1.78
-0.06[-3.26%]
At close: Apr 24
$1.78
0[0.00%]
After Hours: 4:02PM EDT
Aadi Bioscience
(NASDAQ:AADI)Aadi Bioscience Stock (NASDAQ:AADI), Analyst Ratings, Price Targets, Predictions
Aadi Bioscience Inc has a consensus price target of $20.2, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Piper Sandler, HC Wainwright & Co., and HC Wainwright & Co. on December 15, 2023, December 15, 2023, and November 13, 2023. With an average price target of $13.67 between Piper Sandler, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 667.79% upside for Aadi Bioscience Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
HC Wainwright & Co.
Jefferies
Cowen & Co.
Ladenburg Thalmann
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Aadi Bioscience
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/15/2023 | AADI | Buy Now | Aadi Bioscience | $1.78 | 180.9% | Piper Sandler | Joseph Catanzaro | $30 → $5 | Maintains | Overweight | Get Alert |
| 12/15/2023 | AADI | Buy Now | Aadi Bioscience | $1.78 | — | HC Wainwright & Co. | Robert Burns | — | Downgrade | Buy → Neutral | Get Alert |
| 11/13/2023 | AADI | Buy Now | Aadi Bioscience | $1.78 | 1922.47% | HC Wainwright & Co. | Robert Burns | $45 → $36 | Maintains | Buy | Get Alert |
| 08/10/2023 | AADI | Buy Now | Aadi Bioscience | $1.78 | 2428.09% | HC Wainwright & Co. | Robert Burns | → $45 | Reiterates | Buy → Buy | Get Alert |
| 06/08/2023 | AADI | Buy Now | Aadi Bioscience | $1.78 | 2428.09% | HC Wainwright & Co. | Robert Burns | → $45 | Reiterates | Buy → Buy | Get Alert |
| 05/17/2023 | AADI | Buy Now | Aadi Bioscience | $1.78 | 2428.09% | HC Wainwright & Co. | Robert Burns | → $45 | Reiterates | Buy → Buy | Get Alert |
| 03/29/2023 | AADI | Buy Now | Aadi Bioscience | $1.78 | 2428.09% | HC Wainwright & Co. | Robert Burns | $48 → $45 | Maintains | Buy | Get Alert |
| 04/11/2022 | AADI | Buy Now | Aadi Bioscience | $1.78 | 2596.63% | HC Wainwright & Co. | Robert Burns | $735 → $720 | Maintains | Buy | Get Alert |
| 01/11/2022 | AADI | Buy Now | Aadi Bioscience | $1.78 | 2428.09% | Jefferies | Roger Song | → $675 | Initiates | → Buy | Get Alert |
| 11/24/2021 | AADI | Buy Now | Aadi Bioscience | $1.78 | 2652.81% | HC Wainwright & Co. | Robert Burns | — | Maintains | Buy | Get Alert |
| 10/01/2021 | AADI | Buy Now | Aadi Bioscience | $1.78 | — | Cowen & Co. | Boris Peaker | — | Initiates | → Outperform | Get Alert |
| 09/14/2021 | AADI | Buy Now | Aadi Bioscience | $1.78 | 2765.17% | Ladenburg Thalmann | — | — | Initiates | → Buy | Get Alert |
| 09/08/2021 | AADI | Buy Now | Aadi Bioscience | $1.78 | 2428.09% | Piper Sandler | Joseph Catanzaro | — | Initiates | → Overweight | Get Alert |
| 08/30/2021 | AADI | Buy Now | Aadi Biosciences, Inc. - Common Stock | $1.78 | 2540.45% | HC Wainwright & Co. | Robert Burns | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Aadi Bioscience (AADI)?
The latest price target for Aadi Bioscience (NASDAQ: AADI) was reported by Piper Sandler on December 15, 2023. The analyst firm set a price target for $5.00 expecting AADI to rise to within 12 months (a possible 180.90% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aadi Bioscience (AADI)?
The latest analyst rating for Aadi Bioscience (NASDAQ: AADI) was provided by Piper Sandler, and Aadi Bioscience maintained their overweight rating.
When was the last upgrade for Aadi Bioscience (AADI)?
There is no last upgrade for Aadi Bioscience.
When was the last downgrade for Aadi Bioscience (AADI)?
The last downgrade for Aadi Bioscience Inc happened on December 15, 2023 when HC Wainwright & Co. changed their price target from N/A to N/A for Aadi Bioscience Inc.
When is the next analyst rating going to be posted or updated for Aadi Bioscience (AADI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aadi Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aadi Bioscience was filed on December 15, 2023 so you should expect the next rating to be made available sometime around December 15, 2024.
Is the Analyst Rating Aadi Bioscience (AADI) correct?
While ratings are subjective and will change, the latest Aadi Bioscience (AADI) rating was a maintained with a price target of $30.00 to $5.00. The current price Aadi Bioscience (AADI) is trading at is $1.78, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.